Enrolment completed in stem cell trial for osteoarthritis – Australian Life Scientist
ABN Newswire |
Enrolment completed in stem cell trial for osteoarthritis
Australian Life Scientist Regenerative medicine company Regeneus (ASX:RGS) has completed the enrolment of all 20 patients in its STEP trial — the first clinical trial of the company's allogeneic off-the-shelf mesenchymal stem cell (MSC) product for the treatment of knee … Regeneus Ltd (ASX:RGS) Enrolment Complete and Positive Safety in Progenza Trial For Osteoarthritis |
